| pubmed-article:19397268 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19397268 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:19397268 | lifeskim:mentions | umls-concept:C0017205 | lld:lifeskim |
| pubmed-article:19397268 | lifeskim:mentions | umls-concept:C0596988 | lld:lifeskim |
| pubmed-article:19397268 | lifeskim:mentions | umls-concept:C0220781 | lld:lifeskim |
| pubmed-article:19397268 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
| pubmed-article:19397268 | lifeskim:mentions | umls-concept:C0205250 | lld:lifeskim |
| pubmed-article:19397268 | lifeskim:mentions | umls-concept:C1707689 | lld:lifeskim |
| pubmed-article:19397268 | lifeskim:mentions | umls-concept:C2828102 | lld:lifeskim |
| pubmed-article:19397268 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:19397268 | pubmed:dateCreated | 2009-5-22 | lld:pubmed |
| pubmed-article:19397268 | pubmed:abstractText | Highly potent N-substituted delta-lactams have been rationally designed and synthesized by a concise route with a one-pot tandem reaction as key step. These iminosugars show weak inhibition of wild-type beta-glucocerebrosidase but 3- to 6-fold increases in mutant enzyme activity (N370S). | lld:pubmed |
| pubmed-article:19397268 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19397268 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19397268 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19397268 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19397268 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19397268 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19397268 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19397268 | pubmed:month | May | lld:pubmed |
| pubmed-article:19397268 | pubmed:issn | 1520-4804 | lld:pubmed |
| pubmed-article:19397268 | pubmed:author | pubmed-author:ButtersTerry... | lld:pubmed |
| pubmed-article:19397268 | pubmed:author | pubmed-author:ZhouJianJ | lld:pubmed |
| pubmed-article:19397268 | pubmed:author | pubmed-author:ZhangLi-HeLH | lld:pubmed |
| pubmed-article:19397268 | pubmed:author | pubmed-author:Xin-ShanYeY | lld:pubmed |
| pubmed-article:19397268 | pubmed:author | pubmed-author:ZhangLiang-Re... | lld:pubmed |
| pubmed-article:19397268 | pubmed:author | pubmed-author:Reinkensmeier... | lld:pubmed |
| pubmed-article:19397268 | pubmed:author | pubmed-author:ZhangSi-WeiSW | lld:pubmed |
| pubmed-article:19397268 | pubmed:author | pubmed-author:WangGuan-NanG... | lld:pubmed |
| pubmed-article:19397268 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19397268 | pubmed:day | 28 | lld:pubmed |
| pubmed-article:19397268 | pubmed:volume | 52 | lld:pubmed |
| pubmed-article:19397268 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19397268 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19397268 | pubmed:pagination | 3146-9 | lld:pubmed |
| pubmed-article:19397268 | pubmed:meshHeading | pubmed-meshheading:19397268... | lld:pubmed |
| pubmed-article:19397268 | pubmed:meshHeading | pubmed-meshheading:19397268... | lld:pubmed |
| pubmed-article:19397268 | pubmed:meshHeading | pubmed-meshheading:19397268... | lld:pubmed |
| pubmed-article:19397268 | pubmed:meshHeading | pubmed-meshheading:19397268... | lld:pubmed |
| pubmed-article:19397268 | pubmed:meshHeading | pubmed-meshheading:19397268... | lld:pubmed |
| pubmed-article:19397268 | pubmed:meshHeading | pubmed-meshheading:19397268... | lld:pubmed |
| pubmed-article:19397268 | pubmed:meshHeading | pubmed-meshheading:19397268... | lld:pubmed |
| pubmed-article:19397268 | pubmed:meshHeading | pubmed-meshheading:19397268... | lld:pubmed |
| pubmed-article:19397268 | pubmed:meshHeading | pubmed-meshheading:19397268... | lld:pubmed |
| pubmed-article:19397268 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19397268 | pubmed:articleTitle | Rational design and synthesis of highly potent pharmacological chaperones for treatment of N370S mutant Gaucher disease. | lld:pubmed |
| pubmed-article:19397268 | pubmed:affiliation | State Key Laboratory of Natural and Biomimetic Drugs and School of Pharmaceutical Sciences, Peking University, Xue Yuan Road No. 38, Beijing 100191, China. | lld:pubmed |
| pubmed-article:19397268 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19397268 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:19397268 | lld:chembl |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19397268 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19397268 | lld:pubmed |
